Jeffrey Cohen
Analyst, Lavinberg Thalmann
Replay available
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) Q2 2025 earnings conference call, held 2025-05-13. Replay captured from the company's public earnings webcast.

Analyst, Lavinberg Thalmann
Chief Operating Officer
Chief Executive Officer
Chief Financial Officer
Watch the replay and follow the connected company analysis, news, and investor updates for Neuroone Medical Technologies Corporation.
WEBVTT 00:00:00.031 -- 00:00:05.477 Good day, ladies and gentlemen. Welcome to the second quarter of fiscal year 2025 00:00:05.477 -- 00:00:11.524 Financial Results Conference Call for Norah One Medical Technologies Corporation. 00:00:11.524 -- 00:00:16.609 Today's call will be conducted by the company's Chief Executive Officer, Dave Rosa, and 00:00:16.609 -- 00:00:20.333 Ron McClurg, the company's Chief Financial Officer. 00:00:20.333 -- 00:00:25.717 Chris Voelker, the company's Chief Operating Officer, will also be in attendance. 00:00:25.985 -- 00:00:30.415 Before I turn the call over to Mr. Rosa, I'd like to remind you that this conference 00:00:30.415 -- 00:00:34.403 call will include forward-looking statements within the meaning of U.S. 00:00:34.403 -- 00:00:39.535 federal securities laws with respect to future operations, financial 00:00:39.535 -- 00:00:44.710 results, events, trends, and performance. which are based on management's beliefs 00:00:44.710 -- 00:00:49.335 and assumptions as of today's call or other specified date. 00:00:49.335 -- 00:00:54.420 Forward-looking statements, including statements regarding our fiscal 2025 guidance, 00:00:54.420 -- 00:00:59.646 may involve known and unknown risks, uncertainties, and other factors 00:00:59.646 -- 00:01:04.751 which may cause actual results to differ materially from those expressed or implied 00:01:04.751 -- 00:01:10.247 by such statements. See NORA 1's financial results press release and SEC 00:01:10.247 -- 00:01:15.334 filings for information regarding specific risks and uncertainties that could 00:01:15.334 -- 00:01:20.781 cause actual results to differ. Except as required by law, NORA 1 undertakes 00:01:20.781 -- 00:01:24.465 no obligation to update such forward-looking statements. 00:01:24.465 -- 00:...